Ligand Pharmaceuticals Inc (LGND)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.06% 47.63	45.33	42.81	51.81	41.53
Operating Expenses	51.95% 39.18	81.55	52.45	48.67	60.63
Benefits Costs and Expenses	61.89% 36.40	95.51	82.01	58.15	106.92
Costs And Expenses	61.89% 36.40	95.51	82.01	58.15	106.92
Operating Income/Loss	123.32% 8.444	-36.22	-9.637	3.143	-19.10
Nonoperating Income/Loss	119.90% 2.779	-13.96	-29.56	-9.482	-46.29
Income/Loss From Equity Method Investments	-	-	-1.245	-1.194	-8.03
Income/Loss From Continuing Operations Before Tax	122.37% 11.22	-50.18	-39.20	-6.339	-65.39
Income Tax Expense/Benefit	182.49% 6.376	-7.729	-8.112	0.833	-13.48
Income/Loss From Continuing Operations After Tax	111.42% 4.847	-42.45	-31.09	-7.172	-51.91
Net Income/Loss	111.42% 4.847	-42.45	-31.09	-7.172	-51.91
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.71% 19.33	19.19	0.229	18.42	18.03
Diluted Average Shares	3.83% 19.93	19.19	-0.284	18.42	18.03
Basic Earnings Per Share	111.31% 0.25	-2.21	-1.72	-0.39	-2.88
Diluted Earnings Per Share	110.86% 0.24	-2.21	-1.68	-0.39	-2.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$36.94

0.74%

INCY

$92.59

2.67%

GMAB

$28.67

0.97%

BNTX

$104.67

1.28%

ONC

$308.22

2.11%

INSM

$194.22

16.33%